Role of chromatin disruption and histone acetylation in thyroid hormone receptor action: Implications in the regulation of HIV-1 LTR

Histology and Histopathology

Volumn 18, Issue 1, 2003, Pages 323-331

  Hsia, S C V ^a   Tomita, A ^a   Obata, K ^a   Paul, B ^a   Buchholz, D ^a   Shi, Yun Bo ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

AIDS; Chromatin; Histone acetylation; HIV; Thyroid hormone receptor

Indexed keywords

DNA; HISTONE; HISTONE DEACETYLASE; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ACETYLATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; CHROMATIN STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FROG; GENE ACTIVATION; GENE REPRESSION; GENETIC REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LONG TERMINAL REPEAT; MICROINJECTION; NONHUMAN; OOCYTE; RECEPTOR BINDING; REVIEW; TRANSCRIPTION REGULATION;

ACETYLATION; BASE SEQUENCE; CHROMATIN; GENE EXPRESSION REGULATION, VIRAL; HISTONES; HIV LONG TERMINAL REPEAT; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, THYROID HORMONE; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

ANIMALIA; ANURA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037215985     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Alland L., Muhle R., Hou H. Jr, Potes J., Chin L., Schreiber-Agus N. and DePinho R.A. (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55.
2. Almouzni G., Clark D.L., Mechali M. and Wolffe A.P. (1990). Chromatin assembly on replicating DNA in vitro. Nucl. Acids Res. 18, 5767-5774.
3. Bernal J. and Andersson L.C. (1984). The nuclear 3,5,3′-triiodothyronine receptor in human leukaemic cell lines. Acta Endocrinol. 105, 429-432.
4. Burke L.J. and Baniahmad A. (2000). Co-repressors 2000. FASEB J. 14, 1876-1888.
5. Chen J.D. and Li H. (1998). Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Cri. Rev. Eukaryot. Gene Express. 8, 169-190.
6. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y. and Evans R.M. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
7. Chen H., Richar J.L., Xie W., Wilpitz D. and Evans R.M. (1999). Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686.
8. Davey J.C., Schneider M.J. and Galton V.A. (1994). Cloning of a thyroid hormone-responsive Rana catesbeiana c-erbA-beta gene. Dev Genet 15, 339-346.
9. Desai-Yajnik V. and Samuels H.H. (1993). The NF-kB and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol. Cell. Biol. 13, 5057-5069.
10. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., Tenbaum S.P., Renkawitz R. and Baniahmad A. (1999). Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 3383-3394.
11. Evans R.M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
12. Fondell J.D., Roy A.L. and Roeder R.G. (1993). Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: Implications for active repression. Genes Dev. 7, 1400-1410.
13. Freake H.C. and Oppenheimer J.H. (1995). Thermogenesis and thyroid function. Annu. Rev. Nutr. 15, 263-291.
14. Gu W. and Roeder R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
15. Guenther M.G., Lane W.S., Fischle W., Verdin E., Lazar M.A. and Shiekhattar R. (2000). A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14, 1048-1057.
16. Guernsey D.L. and Edelman I.S. (1983). Regulation of thermogenesis by thyroid hormones. In: Molecular Basis of Thyroid Hormone Action. Oppenheimer J. and Samuels H. (eds). Academic Press. New York. pp 293-324.
17. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L. and Ayer D.E. (1997). Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 34134-7.
18. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., Yang W.M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K. and Fosenfled M.G. (1997). A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.
19. Hetzel B.S. (1989). The Story of Iodine Deficiency: An International Challenge in Nutrition. Oxford University Press, Oxford.
20. Hsia S.-C.V. and Shi Y.-B. (2002). Chromatin disruption and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor. Mol. Cell Biol. 22, 4043-4052.
21. Hsia S.-C.V., Wang H. and Shi Y.-B. (2001). Involvement of chromatin and histone acetylation in the regulation of HIV-LTR by thyroid hormone receptor. Cell Res. 11, 8-16.
22. Hu X. and Lazar M.A. (2000). Transcriptional repression by nuclear hormone receptors. TEM 11: 1, 6-10.
23. Huang E.Y., Zhang J., Miska E.A., Guenther M.G., Kouzarides T. and Lazar M.A. (2000). Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway Genes Dev. 14, 45-54.
24. Imhof A., Yang X.J., Ogryzko V.V., Nakatani Y., Wolffe A.P. and Ge H. (1997). Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7, 689-692.
25. Ito M. and Roeder R.G. (2001). The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends Endocrinol. Metab. 12, 127-134.
26. Ito M., Yuan C.-X., Malik S., Gu W., Fondell J.D., Yamamura S., Fu Z.Y., Zhang X., Qin J. and Roeder R.G. (1999). Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell 3, 361-370.
27. Jones P.L., Sachs L.M., Rouse N., Wade P.A. and Shi Y.B. (2001). Multiple N-CoR complexes contain distinct histone deacetylases. J. Biol. Chem. 276, 8807-8811.
28. Kornberg R.D. and Lorch Y. (1995). Interplay between chromatin structure and transcription. Curr. Opin. Cell. Biol. 7, 371-375.
29. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E. and Eisenman R.N. (1997). Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356.
30. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., Tsai M.J. and O'Malley B.W. (1999). A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97, 17-27.
31. Larsen P.R. (1989). Maternal thyroxine and congenital hypothyroidism. N. Engl. J. Med. 321, 444-446.
32. Lewin B. (1994). Chromatin and gene expression: Constant questions, but changing answers. Cell 79, 397-406.
33. Li J., O'Malley B.W. and Wong J. (2000a). p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin. Mol. Cell. Biol. 20, 2031-2042.
34. Li J., Wang J., Nawaz Z., Liu J.M., Qin J. and Wong J. (2000b). Both corepressor proteins SMRT and C-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350.
35. Li Q., Imhof A., Collingwood T.N., Urnov F.D. and Wolffe A.P. (1999). p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption. EMBO J. 18, 5634-5652.
36. Lopresti J.S., Fried J.C., Spencer C.A. and Nicoloff J.T. (1989). Unique alterations of thyroid-hormone indexes in the acquired immunodeficiency syndrome (Aids). Ann. Intern. Med. 110, 970-975.
37. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. and Evans R.M. (1995). The nuclear receptor superfamily: The second decade. Cell 83, 835-839.
38. McKenna N.J., Lanz R.B. and O'Malley B.W. (1999). Nuclear receptor coregulators: Cellular and molecular biology. Endocr. Rev. 20, 321-344.
39. McKenna N.J., Nawaz Z., Tsai S.Y., Tsai M.J. and O'Malley B.W. (1998). Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. USA 95, 11697-11702.
40. Nagy L., Kao H.Y., Charkaravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L. and Evans R.M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
41. Narlikar G.J., Fan H.-Y. and Kingston R. (2002). Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487.
42. Oppenheimer J.H. (1979). Thyroid hormone action at the cellular level. Science 203, 971-979.
43. Oppenheimer J.H., Schwartz H.L., Mariash C.N., Kinlaw W.B., Wong N.C. and Freake H.C. (1987). Advances in our understanding of thyroid hormone action at the cellular level. Endocr. Rev. 8, 288-308.
44. Pereira L.A., Bentley K., Peeters A., Churchill M.J. and Deacon N.J. (2000). A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nuclei Acids Research 28, 663-668.
45. Perlman A.J., Stanley F. and Samuels H.H. (1982). Thyroid hormone nuclear receptor. Evidence for multimeric organization in chromatin. J. Biol. Chem. 257, 930-938.
46. Puzianowsak-Kuznicka M., Damjanovski S. and Shi Y.-B. (1997). Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis. Mol. Cell. Biol. 17, 4738-4749.
47. Puzianowsak-Kuznicka M., Wong J., Kanamori A. and Shi Y.-B. (1996). Functional characterization of a mutant thyroid hormone receptor in Xenopus laevis. J. Biol. Chem. 271, 33394-33403.
48. Rachez C. and Freedman L.P. (2000). Mechanisms of gene regulation by vitamin D(3) receptor: A network of coactivator interactions. Gene 246, 9-21.
49. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P. and Freedman L.P. (1999). Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828.
50. Rahman A., Esmaili A. and Saatcioglu F. (1995). A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites. J. Biol. Chem. 270, 31059-31064.
51. Ranjan M., Wong J. and Shi Y.B. (1994). Transcriptional repression of Xenopus TR beta gene is mediated by a thyroid hormone response element located near the start site. J. Biol. Chem. 269, 24699-24705.
52. Ryu S., Zhou S., Ladurner A.G. and Tjian R. (1999). The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397, 446-450.
53. Sachs L.M. and Shi Y.-B. (2000). Targeted chromatin binding and histone acetylation in vivo by thyroid hormone receptor during amphibian development. Proc. Natl. Acad. Sci. USA 97, 13138-13143.
54. Sap J., Munoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H. and Vennstrom B. (1986). The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324, 635-640.
55. Sheridan P.L., Mayall T.P., Verdin E. and Jones K.A. (1997). Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11, 3324-3340.
56. Shi Y.B., Fu L., Hsia S.C., Tomita A and Buchholz D. (2001). Thyroid hormone regulation of apoptotic tissue remodeling during anuran metamorphosis. Cell Res. 11, 245-252.
57. Silva J.E. (1995). Thyroid hormone control of thermogenesis and energy balance. Thyroid 5, 481-492.
58. Steger D.J., Eberharter A., John S., Grant P.A. and Wokman J.L. (1998). Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc. Natl. Acad. Sci. USA 95, 12924-12929.
59. Strahl B.D. and Allis C.D. (2000). The language of covalent histone modifications. Nature 403, 41-45.
60. Svaren J. and Horz W. (1993). Histones, nucleosomes and transcription. Curr. Opin. Gen. Dev. 3, 219-225.
61. Tang W.W. and Kaptein E.M. (1989). Thyroid-hormone levels in the acquired immunodeficiency syndrome (Aids). Western J. Med. 151, 627-631.
62. Tsai M.J. and O'Malley B.W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
63. Underhill C., Qutob M.S., Yee S.P. and Torchia J. (2000). A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1 J. Biol. Chem. 275, 40463-4070.
64. Urnov F.D., Yee J., Sachs L., Collingwood T.N., Bauer A., Beug H., Shi Y.B. and Wolffe A.P. (2000). Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway. EMBO J. 19, 4074-4090.
65. Vaishnav Y.N. and Wong-Staal F. (1991). The biochemistry of AIDS. Annu. Rev. Biochem. 60, 577-630.
66. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J. and Evans R.M. (1986). The c-erb-A gene encodes a thyroid hormone receptor. Nature 324, 641-646.
67. Wolffe A.P. (1997). Chromatin remodeling regulated by steroid and nuclear receptors. Cell Res. 7, 127-142.
68. Wolffe A.P. (1998). Chromatin: Structure and Function. 3rd Edition Academic Press. London.
69. Wong J., Patterton D., Imhof D., Guschin D., Shi Y.-B. and Wolffe A.P. (1998). Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. EMBO J. 17, 520-534.
70. Wong J., Shi Y.-B. and Wolffe A.P. (1997). Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: Hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J. 16, 3158-3171.
71. Wong J., Shi Y.B. and Wolffe A.P. (1995). A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor. Genes Dev. 9, 2696-2711.
72. Workman J.L. and Kingston R.E. (1998). Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67, 545-579.
73. Xu J., Luznik L., Wong-Staal F. and Gill G.N. (1996). Hormone receptor regulation of the human immunodeficiency virus type 1 and type 2 long terminal repeats. J. Biomed. Sci. 3, 323-331.
74. Xu L., Glass C.K. and Rosenfeld M.G. (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr. Op. Genet. Dev. 9, 140-147.
75. Yen P.M. (2001). Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-142.
76. Yen P.M. and Chin W.W. (1994). New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol. Metab. 5, 65-72.
77. Zhang J. and Lazar M.A. (2000). The mechanism of action of thyroid hormones. Annu. Rev. Physiol. 62, 439-466.